CORRECTED-Living-donor liver transplantation has long-term advantages in children
Last Updated: 2018-02-07
(Modifies headline and first paragraph, to clarify study findings, and adds new paragraph 6.)
By Will Boggs MD
NEW YORK (Reuters Health) - Living-donor liver transplantation has durable clinical and immunological benefits in pediatric transplant patients, according to a retrospective study.
"Our findings provide strong support for a more confident recommendation of living donor as the best option for children needing liver transplantation," said Dr. Eric M. Przybyszewski from Columbia University Medical Center, in New York City.
"Our data demonstrating that grafts from living donors have lower long-term immunologic risks compared to grafts from deceased donors provides support for this recommendation," he told Reuters Health by email.
Living-donor liver transplantation (LDLT) has been used successfully for pediatric recipients for nearly 30 years, yet long-term benefits have yet to be shown.
Last Updated: 2018-02-07
(Modifies headline and first paragraph, to clarify study findings, and adds new paragraph 6.)
By Will Boggs MD
NEW YORK (Reuters Health) - Living-donor liver transplantation has durable clinical and immunological benefits in pediatric transplant patients, according to a retrospective study.
"Our findings provide strong support for a more confident recommendation of living donor as the best option for children needing liver transplantation," said Dr. Eric M. Przybyszewski from Columbia University Medical Center, in New York City.
"Our data demonstrating that grafts from living donors have lower long-term immunologic risks compared to grafts from deceased donors provides support for this recommendation," he told Reuters Health by email.
Living-donor liver transplantation (LDLT) has been used successfully for pediatric recipients for nearly 30 years, yet long-term benefits have yet to be shown.
No comments:
Post a Comment